B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Neuro-Oncology

• Publication date

  2008-05-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11060-008-9601-xPMID 18478183
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cancer BioMed Central

  2008cited by this paper
• The new B7s: playing a pivotal role in tumor immunity.

  2007cited by this paper
• CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

  2007influential reference
• Proliferative status of tumor stem cells may be correlated with malignancy grade of human astrocytomas.

  2007cited by this paper
• Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

  2006cited by this paper
• B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

  2006influential reference
• B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006cited by this paper
• B7-H3 and B7-H4 expression in non-small-cell lung cancer.

  2006cited by this paper
• Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulation.

  2005cited by this paper
• Stem Cells,Cancer and Cancer Stem Cells

  2005cited by this paper
• Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin.

  2005cited by this paper
• The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.

  2005cited by this paper
• T-cell immune responses in the brain and their relevance for cerebral malignancies.

  2003cited by this paper
• Identification of a cancer stem cell in human brain tumors.

  2003cited by this paper
• B7x: A widely expressed B7 family member that inhibits T cell activation

  2003cited by this paper
• Cancerous stem cells can arise from pediatric brain tumors

  2003cited by this paper
• B7S1, a novel B7 family member that negatively regulates T cell activation.

  2003cited by this paper
• B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.

  2003cited by this paper
• Recruitment of leukemic cells from G0 phase of the cell cycle by interferons results in conversion of resistance to daunorubicin

  2003cited by this paper
• Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family 1

  2003cited by this paper
• Impact of Proliferation Index on Outcome in Childhood Malignant Gliomas: Results in a Multi-institutional Cohort

  2002cited by this paper
• Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies.

  2002cited by this paper
• The WHO Classification of Tumors of the Nervous System

  2002cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Prognostic significance of Ki‐67 labeling indices obtained using MIB‐1 monoclonal antibody in patients with supratentorial astrocytomas

  1996cited by this paper
• Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

  1984cited by this paper

• The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy

  2025cites this paper
• Glioblastoma Stem Cells at the Nexus of Tumor Heterogeneity, Immune Evasion, and Therapeutic Resistance

  2025cites this paper
• Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies

  2024cites this paper
• Cancer stem cell mimicry for immune evasion and therapeutic resistance.

  2024cites this paper
• Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status

  2024cites this paper
• Alternative immune checkpoints in immunoregulatory profile of cancer stem cells

  2023cites this paper
• The co-inhibitory immune checkpoint proteins B7-H1(PD-L1) and B7-H4 in high grade glioma: From bench to bedside

  2023cites this paper
• Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications

  2023cites this paper
• Glioma targeted therapy: insight into future of molecular approaches

  2022cites this paper
• Glioma Stem Cells: Novel Data Obtained by Single-Cell Sequencing

  2022cites this paper
• Cancer resistance to immunotherapy: What is the role of cancer stem cells?

  2022cites this paper
• Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy

  2022cites this paper
• Biphenyl-based small molecule inhibitors: Novel cancer immunotherapeutic agents targeting PD-1/PD-L1 interaction.

  2022cites this paper
• Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs

  2021cites this paper
• B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness.

  2021cites this paper
• The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure

  2021cites this paper
• TERT Promoter Alterations in Glioblastoma: A Systematic Review

  2021cites this paper
• Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy

  2019cites this paper
• Therapeutic targeting of immune checkpoints with small molecule inhibitors.

  2019cites this paper
• Expression of inhibitory checkpoint ligands by Glioblastoma Multiforme cells and the implications of an enhanced stem cell-like phenotype

  2019cites this paper
• B7-H4, a promising target for immunotherapy.

  2019cites this paper
• Immune Checkpoints of the B7 Family. Part 2. Representatives of the B7 Family B7-H3, B7-H4, B7-H5, B7-H6, B7-H7, and ILDR2 and Their Receptors

  2019cites this paper
• 非小细胞肺癌脑转移免疫治疗的相关肿瘤微环境基础

  2019cites this paper
• Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.

  2019cites this paper
• Immunomodulatory roles of nitric oxide in cancer: tumor microenvironment says "NO" to antitumor immune response.

  2019cites this paper
• The role of cancer stem cells in the modulation of anti-tumor immune responses.

  2018cites this paper
• Immune ligands for cytotoxic T Lymphocytes (CTLS) in cancer stem cells (CSCS).

  2018influential citation
• Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial

  2018cites this paper
• Brain Tumor Treatment: 2017 Update

  2018cites this paper
• Immune modulation by a cellular network of mesenchymal stem cells and breast cancer cell subsets: Implication for cancer therapy.

  2017cites this paper
• Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor‐Like Stem Cells in Basal Breast Cancers

  2017cites this paper
• New checkpoints in cancer immunotherapy

  2017cites this paper
• Tumor cell-associated immune checkpoint molecules - Drivers of malignancy and stemness.

  2017cites this paper
• Research on human glioma stem cells in China

  2017cites this paper
• Tumors B 7-H 4 ( B 7 x ) – Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL 6 / JAK / STAT 3 Pathway Lead to Poor Prognosis in Glioma Patients

  2016cites this paper
• B7-H4(B7x)–Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients

  2016cites this paper
• Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

  2016cites this paper
• Resistance of Cancer Stem Cells to Cell-Mediated Immune Responses

  2015cites this paper
• The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?

  2015cites this paper
• Immune responses to human cancer stem‐like cells/cancer‐initiating cells

  2015cites this paper
• B7 family checkpoint regulators in immune regulation and disease.

  2013cites this paper
• Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors

  2013cites this paper
• B7-H4’s Role “Beyond the Tumor”

  2013cites this paper
• Host B 7 x Promotes Pulmonary Metastasis of Breast Cancer

  2013cites this paper
• Cancer stem cell contribution to glioblastoma invasiveness

  2013cites this paper
• Anti-B7-H4

  2013cites this paper
• Host B7x Promotes Pulmonary Metastasis of Breast Cancer

  2013cites this paper
• The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma

  2013cites this paper
• B7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium

  2013cites this paper
• Immunomodulatory Functions of Cancer Stem Cells

  2012cites this paper
• Differential proliferative index of cancer stem-like cells in primary and recurrent medulloblastoma in human

  2012cites this paper
• Liangfu Zhou: Clinical neurosurgeon, Academician, teacher, and friend.

  2012cites this paper
• Expression of Costimulatory Molecule B7-H4 in Human Malignant Tumors

  2012cites this paper
• The expression, function, and clinical relevance of B7 family members in cancer

  2012cites this paper
• Tissue Prognostic Factors in Melanoma: Expression of B7 Family Members B7-H3 and B7-H4 and Death Receptors TRAIL-R1 and TRAILR2

  2012cites this paper
• B7-H4 expression and increased death risk of cancer patients: A meta-analysis

  2011cites this paper
• Glioma-initiating cells and molecular pathology: implications for therapy

  2011cites this paper
• The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma

  2011cites this paper
• T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.

  2011cites this paper
• B7‐H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells

  2010cites this paper
• Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients

  2010cites this paper
• DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy

  2009cites this paper
• B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells.

  2009cites this paper
• DNA repair in normal and cancer stem cells, with special reference to the central nervous system.

  2009cites this paper
• Brain tumor stem cells: view from cell proliferation.

  2009cites this paper
• Fine tuning the immune response through B7‐H3 and B7‐H4

  2009cites this paper
• The complex role of B7 molecules in tumor immunology.

  2008cites this paper